Fundraising FoxRange VC — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Cascade Bio develops enzyme immobilization technology ("Body Armor"), a silica-based coating applied to glass-bead supports that stabilizes enzymes so they last longer and tolerate harsher conditions than other cell-free solutions.
BiotechCleantechClimate TechDeep TechNew MaterialsDenver, US
James Weltz(Executive Officer, Director, Promoter)inAlex Rosay(Co-founder)in
BoardJared Campbell(Director)
Co-investors1Flourish CapitalAmplify.LACool Climate CollectiveEndurance28R7 PartnersSpacecadet Ventures+4 more
Cime Therapeutics is developing a chemistry-first drug discovery platform that combines automation, AI/ML, and synthetic chemistry to make molecules faster and more cost-effectively.
AI & Machine LearningBiotechDeep TechDenver, US
James Brewster(Chief Executive Officer)inJames Thomas Brewster II(Executive Officer, Director)James Brewster, Ph.D.(Chief Executive Officer)
BoardChris Erickson(Director)in
Co-investorsCreative Destruction Lab (CDL)DYDX CapitalService Provider Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.